Cuba developing its own version of an antiretroviral for use in coronavirus patients

Cuba is developing, with “satisfactory” preliminary results, its own version of the antiviral Kaletra, with the aim of eliminating its import and guaranteeing a stable supply of the drug, created to treat HIV-AIDS and now used in COVID-19 patients. The Cuban retroviral prototype, a combination of lopinavir and ritonavir, is still “in the development stage,” … Continue reading Cuba developing its own version of an antiretroviral for use in coronavirus patients